Insights

Treatment Market Expansion Corcept Therapeutics introduced Korlym, the first FDA-approved treatment for Cushing's syndrome, in 2012, indicating a strong foothold in the hypercortisolism market with potential for further market penetration and growth.

Investment Interest Noteworthy investments from Algert Global LLC, Evergreen Capital Management LLC, Cetera Advisors LLC, Intrinsic Edge Capital Management, and other firms showcase investor confidence in Corcept Therapeutics, highlighting potential partnerships and sales collaborations.

Legal Challenges Legal issues with Teva's antitrust lawsuit alleging monopoly over the Korlym market present an opportunity for Corcept Therapeutics to showcase transparency, integrity, and commitment to fair market practices, potentially attracting ethical investors and strategic partners.

Growing Financial Strength With a revenue range of $50-100 million and recent funding of $525k, Corcept Therapeutics displays strong financial health, indicating capacity for further research, development, and expansion into new markets or product lines, offering opportunities for sales growth.

Strategic Investor Interest Investments from Castle Rock, CO, Jackson Creek Investment Advisors LLC, and other entities signify strategic interest in Corcept Therapeutics, suggesting potential for long-term collaborations, joint ventures, or acquisitions that could drive sales growth and market visibility.

Corcept Therapeutics Tech Stack

Corcept Therapeutics uses 8 technology products and services including Cloudinary, Medrio, Font Awesome, and more. Explore Corcept Therapeutics's tech stack below.

  • Cloudinary
    Content Delivery Network
  • Medrio
    Electronic Health Records
  • Font Awesome
    Font Scripts
  • Lightbox
    Javascript Libraries
  • Office 365
    Office Suites
  • Python
    Programming Languages
  • Greenhouse
    Recruitment Marketing
  • Concur
    Travel And Expense Management

Corcept Therapeutics's Email Address Formats

Corcept Therapeutics uses at least 1 format(s):
Corcept Therapeutics Email FormatsExamplePercentage
FLast@corcept.comJDoe@corcept.com
95%
FiLast@corcept.comJoDoe@corcept.com
3%
LastFir@corcept.comDoeJoh@corcept.com
1%
First.Last@corcept.comJohn.Doe@corcept.com
1%

Frequently Asked Questions

Where is Corcept Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Corcept Therapeutics's main headquarters is located at 101 Redwood Shores Pkwy Redwood City, California 94065 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Corcept Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Corcept Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Corcept Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Corcept Therapeutics is a publicly traded company; the company's stock symbol is CORT.

What is Corcept Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Corcept Therapeutics's official website is corcept.com and has social profiles on LinkedIn.

How much revenue does Corcept Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Corcept Therapeutics's annual revenue reached $75M.

What is Corcept Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Corcept Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Corcept Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Corcept Therapeutics has approximately 499 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. B.Chief Human Resources And Communications Officer: A. F.Chief Development Officer (cdo): W. B. G.. Explore Corcept Therapeutics's employee directory with LeadIQ.

What industry does Corcept Therapeutics belong to?

Minus sign iconPlus sign icon
Corcept Therapeutics operates in the Biotechnology Research industry.

What technology does Corcept Therapeutics use?

Minus sign iconPlus sign icon
Corcept Therapeutics's tech stack includes CloudinaryMedrioFont AwesomeLightboxOffice 365PythonGreenhouseConcur.

What is Corcept Therapeutics's email format?

Minus sign iconPlus sign icon
Corcept Therapeutics's email format typically follows the pattern of . Find more Corcept Therapeutics email formats with LeadIQ.

How much funding has Corcept Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Corcept Therapeutics has raised $525K in funding. The last funding round occurred on Apr 10, 2012 for $525K.

When was Corcept Therapeutics founded?

Minus sign iconPlus sign icon
Corcept Therapeutics was founded in 1998.
Corcept Therapeutics

Corcept Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

We’ve been unlocking the potential of cortisol modulation for more than 25 years.

We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Section iconCompany Overview

Headquarters
101 Redwood Shores Pkwy Redwood City, California 94065 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
CORT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
201-500

Section iconFunding & Financials

  • $525K

    Corcept Therapeutics has raised a total of $525K of funding over 8 rounds. Their latest funding round was raised on Apr 10, 2012 in the amount of $525K.

  • $50M$100M

    Corcept Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $525K

    Corcept Therapeutics has raised a total of $525K of funding over 8 rounds. Their latest funding round was raised on Apr 10, 2012 in the amount of $525K.

  • $50M$100M

    Corcept Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.